S

SMAIO SA
PAR:ALSMA

Watchlist Manager
SMAIO SA
PAR:ALSMA
Watchlist
Price: 6.2 EUR -3.13% Market Closed
Market Cap: 35m EUR

SMAIO SA
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SMAIO SA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
S
SMAIO SA
PAR:ALSMA
EPS (Diluted)
€0
CAGR 3-Years
9%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Edap Tms SA
NASDAQ:EDAP
EPS (Diluted)
€0
CAGR 3-Years
N/A
CAGR 5-Years
-36%
CAGR 10-Years
-3%
Biomerieux SA
PAR:BIM
EPS (Diluted)
€3
CAGR 3-Years
-12%
CAGR 5-Years
4%
CAGR 10-Years
10%
Implanet SA
PAR:ALIMP
EPS (Diluted)
€0
CAGR 3-Years
42%
CAGR 5-Years
53%
CAGR 10-Years
48%
Diagnostic Medical Systems SA
PAR:ALDMS
EPS (Diluted)
€0
CAGR 3-Years
16%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Amplitude Surgical SA
PAR:AMPLI
EPS (Diluted)
€0
CAGR 3-Years
N/A
CAGR 5-Years
-22%
CAGR 10-Years
N/A
No Stocks Found

SMAIO SA
Glance View

Market Cap
35m EUR
Industry
Health Care

S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 30 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software,

ALSMA Intrinsic Value
11.09 EUR
Undervaluation 44%
Intrinsic Value
Price
S

See Also

What is SMAIO SA's EPS (Diluted)?
EPS (Diluted)
-0.5 EUR

Based on the financial report for Dec 31, 2024, SMAIO SA's EPS (Diluted) amounts to -0.5 EUR.

What is SMAIO SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-7%

Over the last year, the EPS (Diluted) growth was -400%. The average annual EPS (Diluted) growth rates for SMAIO SA have been 9% over the past three years , -7% over the past five years .

Back to Top